Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baohui Han

Showing results (71-80 of 426) with videos related to

Pageof 43
Sort By:
International Immunopharmacology|June 27, 2021
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironmentLian Yu, Shuhui Cao, Jingwen Li, et al.
Molecular and Clinical Oncology|March 24, 2015
Benefit from ifosfamide treatment in small-cell lung cancer: A meta-analysisHuizhen Yang, Yun Ma, Zhida Liu, et al.
Cell Biochemistry and Biophysics|June 21, 2014
Association of POLK polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patientsMinhua Shao, Bo Jin, Yanjie Niu, et al.
Ultrasound in Medicine & Biology|September 11, 2016
Sonographic Features of Endobronchial Ultrasound in Differentiation of Benign Lymph NodesLei Wang, Weihua Wu, Jiajun Teng, et al.
Oncology Letters|July 12, 2012
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLCZhiqiang Gao, Baohui Han, Huimin Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 16, 2011
[Detection of circulating lung cancer cells with cytokeratin and 2F7/S5A monoclonal antibody in patients with lung cancer]Baohui Han, Meiling Liao, Xiaofeng Jiang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 20, 2011
[Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer]Yizhuo Zhao, Yurong Chen, Hao Ji, et al.
Gene|July 3, 2016
Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancerMeiLi Ma, ChunLei Shi, JiaLin Qian, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 23, 2013
[Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma]Xueyan Zhang, Huimin Wang, Bo Jin, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patientRunbo Zhong, Yunbin Zhang, Dongfang Chen, et al.
Pageof 43

Showing results (71-80 of 426) with videos related to

Sort By:
Pageof 43
International Immunopharmacology|June 27, 2021
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironmentLian Yu, Shuhui Cao, Jingwen Li, et al.
Molecular and Clinical Oncology|March 24, 2015
Benefit from ifosfamide treatment in small-cell lung cancer: A meta-analysisHuizhen Yang, Yun Ma, Zhida Liu, et al.
Cell Biochemistry and Biophysics|June 21, 2014
Association of POLK polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patientsMinhua Shao, Bo Jin, Yanjie Niu, et al.
Ultrasound in Medicine & Biology|September 11, 2016
Sonographic Features of Endobronchial Ultrasound in Differentiation of Benign Lymph NodesLei Wang, Weihua Wu, Jiajun Teng, et al.
Oncology Letters|July 12, 2012
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLCZhiqiang Gao, Baohui Han, Huimin Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 16, 2011
[Detection of circulating lung cancer cells with cytokeratin and 2F7/S5A monoclonal antibody in patients with lung cancer]Baohui Han, Meiling Liao, Xiaofeng Jiang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 20, 2011
[Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer]Yizhuo Zhao, Yurong Chen, Hao Ji, et al.
Gene|July 3, 2016
Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancerMeiLi Ma, ChunLei Shi, JiaLin Qian, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 23, 2013
[Correlations between OCT4 expression and clinicopathological factors and prognosis of patients with lung adenocarcinoma]Xueyan Zhang, Huimin Wang, Bo Jin, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patientRunbo Zhong, Yunbin Zhang, Dongfang Chen, et al.
Pageof 43